financetom
Business
financetom
/
Business
/
Datadog Insider Sold Shares Worth $12,984,159, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Datadog Insider Sold Shares Worth $12,984,159, According to a Recent SEC Filing
Mar 14, 2025 1:33 PM

04:10 PM EDT, 03/14/2025 (MT Newswires) -- Alexis Le-Quoc, Director, Chief Technology Officer, on March 12, 2025, sold 127,105 shares in Datadog ( DDOG ) for $12,984,159. Following the Form 4 filing with the SEC, Le-Quoc has control over a total of 372,000 Class A common shares of the company, with 371,865 shares held directly and 135 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1561550/000156155025000078/xslF345X05/wk-form4_1741982511.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
German union slams 'aggressive' Tesla for firing works council rep
German union slams 'aggressive' Tesla for firing works council rep
Oct 17, 2024
BERLIN (Reuters) - German union IG Metall has accused management at US carmaker Tesla's plant near Berlin of aggressive tactics against workers trying to unionise after it fired one of its representatives on the works council. Tesla management dismissed a worker affiliated with IG Metall without notice at the gigafactory plant in Gruenheide, the union said in a statement. This...
Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals
Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals
Oct 17, 2024
Oct 14 (Reuters) - UK-based Cycle Pharmaceuticals on Monday reaffirmed its offer to buy Vanda Pharmaceuticals ( VNDA ) in a deal that values the US drugmaker at $488 million, despite a regulatory setback for its stomach condition drug in September. Vanda in June rejected takeover offers from Cycle Pharma and a revised bid from contract manufacturer Future Pak. WHY...
Affirm Holdings to Benefit From Lower Interest Rate Environment, Wedbush Securities Says
Affirm Holdings to Benefit From Lower Interest Rate Environment, Wedbush Securities Says
Oct 17, 2024
10:32 AM EDT, 10/14/2024 (MT Newswires) -- Affirm Holdings ( AFRM ) is set to benefit from a lower interest rate environment, leading to lower funding costs and incremental growth in gross merchandise volume, or GMV, among others, Wedbush Securities said in a note to clients early Monday. The company has a balanced risk/reward and a number of ancillary GMV...
Market Chatter: HSBC Reviewing China Digital Wealth Business' Expenses, Control
Market Chatter: HSBC Reviewing China Digital Wealth Business' Expenses, Control
Oct 17, 2024
10:31 AM EDT, 10/14/2024 (MT Newswires) -- HSBC Holdings ( HSBC ) started a review of expenses and operational controls at its China digital wealth business Pinnacle a few months ago, Reuters reported Monday, citing several unnamed sources. The bank is looking into staff salary structures and whether suppliers inflated expenses, adding to a sharp increase in costs that exceeded...
Copyright 2023-2026 - www.financetom.com All Rights Reserved